Abstract
Previous murine studies have demonstrated that dietary Aquamin, a calcium-rich, multi-mineral natural product, suppressed colon polyp formation and transition to invasive tumors more effectively than calcium alone when provided over the lifespan of the animals. In the current study, we compared calcium alone to Aquamin for modulation of growth and differentiation in human colon adenomas in colonoid culture. Colonoids established from normal colonic tissue were examined in parallel. Both calcium alone at 1.5 mmol/L and Aquamin (provided at 1.5 mmol/L calcium) fostered differentiation in the adenoma colonoid cultures as compared with control (calcium at 0.15 mmol/L). When Aquamin was provided at an amount delivering 0.15 mmol/L calcium, adenoma differentiation also occurred, but was not as complete. Characteristic of colonoids undergoing differentiation was a reduction in the number of small, highly proliferative buds and their replacement by fewer but larger buds with smoother surface. Proliferation marker (Ki67) expression was reduced and markers of differentiation (CK20 and occludin) were increased along with E-cadherin translocalization to the cell surface. Additional proteins associated with differentiation/growth control [including histone-1 family members, certain keratins, NF2 (merlin), olfactomedin-4 and metallothioneins] were altered as assessed by proteomics. Immunohistologic expression of NF2 was higher with Aquamin as compared with calcium at either concentration. These findings support the conclusions that (i) calcium (1.5 mmol/L) has the capacity to modulate growth and differentiation in large human colon adenomas and (ii) Aquamin delivering 0.15 mmol/L calcium has effects on proliferation and differentiation not observed when calcium is used alone at this concentration. Cancer Prev Res; 11(7); 413–28. ©2018 AACR.
Introduction
Epidemiologic studies have demonstrated a clear (inverse) relationship between calcium intake and incidence of colon polyp formation (1, 2). A recent meta-analysis suggests that the relationship between calcium intake and tumor incidence extends to colon cancer itself (3). Animal studies have confirmed the beneficial activity of dietary calcium in colon polyp prevention, demonstrating both reduced incidence and inhibition of disease progression (4, 5), and studies with epithelial cells in culture have provided mechanistic insight (6).
Although an adequate supply of dietary calcium is functionally related to protection against the formation of colonic adenomas, the use of calcium supplements to mitigate disease risk has shown only modest success. Reduced colon polyp formation has been shown in some chemoprevention studies (7, 8), but others have failed to find significant benefit (9, 10). At the same time, a high intake of calcium supplements is associated with increased risk of unwanted consequences including cardiovascular events (11, 12).
Recent studies from our laboratory have suggested that combining calcium with additional trace elements may provide a way to enhance the beneficial effects of calcium in the colon. Our studies demonstrated that a natural product (Aquamin), consisting of the skeletal remains of red marine algae of the Lithothamnion family (13) and containing magnesium as well as detectable amounts of 72 additional trace elements in addition to calcium, suppressed colon polyp formation and transition to invasive tumors in C57BL/6 mice on a high-fat diet more effectively than calcium alone when included in the diet over the lifespan of the animals (14, 15). In studies with human colon carcinoma cells in monolayer culture, Aquamin was more effective than calcium alone at suppressing tumor cell growth and inducing differentiation (16, 17).
Whether Aquamin will, ultimately, prove to be more effective than calcium alone as a colon polyp chemopreventive agent in humans remains to be seen. A problem with translating preclinical findings to results in humans is the low incidence of colon polyp formation and the long lag period between initial molecular changes and outgrowth of observable lesions. Furthermore, progression from initial polyp formation to more serious disease is difficult to study experimentally as colonic polyps are removed upon detection. Perhaps most important is the high degree of variability in these premalignant lesions from individual to individual. Colonoid culture (colon epithelial organoids) technology (18), which is now well developed, provides a way to study human colon polyp responses to potentially useful chemopreventive agents under ex vivo conditions. Using samples from our own bank of human adenoma colonoids (19–22), we have in the current study assessed the effects of calcium (alone) over a range of concentrations on adenoma colonoid growth and differentiation. In parallel, calcium provided in conjunction with additional trace elements as a natural product (i.e., Aquamin) was evaluated.
Materials and Methods
Human colonoid culture: adenoma-derived and normal colonic mucosa
Colonoid (colon epithelial organoids) cultures were initiated from adenoma tissue obtained by endoscopy. The study was conducted after IRBMED (University of Michigan, Ann Arbor, MI) approval (HUM 00038437), and all subjects signed written informed consent prior to the procedure. The first adenoma (#584) was a 20-mm (diameter) tumor in the ascending colon of a 61-year-old male. It was characterized by mutations in APC, EP300, KRAS, MET, PMS2, and TP53 (22). The second adenoma (#590) was a 35-mm lesion in the ascending colon of a 58-year-old female. Mutations of interest included BUB1B, CTNNA1, CTNNB1, FLCN, MAP2K4, MLH1, MLH3, MSH3, PALB2, PIK3R1 and TCERG1 (22). The third adenoma (#282) was a 45-mm lesion located in the ascending colon of a 66-year-old female. Mutational analysis revealed mutations in APC, ATM, EP300, MSH2, and R909Q (22). Upon arrival in the laboratory, tissue was established in culture as described in our earlier report (19). Briefly, adenoma tissue specimens were propagated in Matrigel (Corning), which was made to 8 mg/mL in growth media, in 6-well tissue culture plates. Culture medium consisted of KGM Gold, a low-calcium (0.15 mmol/L), serum-free formulation containing EGF and pituitary extract as growth supplements. Growth was at 37°C in an atmosphere of 95% air and 5% CO2. Cultures were passaged every 4 to 7 days by digesting Matrigel in cold 2 mmol/L EDTA and plated on the first day with 10 μmol/L Y27632, a ρ-associated protein kinase inhibitor. Short tandem repeat profiling was used throughout the study to confirm colonoid culture identity.
Establishment of colonoid cultures from histologically normal colon tissue followed the same procedure as that used with adenomas. The normal colon tissue was collected from the sigmoid colon of subjects of an ongoing IRBMED (University of Michigan)–approved study (HUM 00076276), and subjects provided informed written consent prior to their participation. Normal colon tissue–derived colonoids were grown in L-WRN medium (includes a source of Wnt, R-spondin, and noggin and is supplemented with 10% FBS; ref. 23). For the current study, L-WRN was diluted 1:4 with KGM Gold, bringing the final serum concentration to 2.5% and the final calcium concentration to 0.25 mmol/L. Preliminary experiments demonstrated survival of normal tissue–derived colonoids for up to 4 weeks in this hybrid culture medium.
Human research ethics statement
These studies involving normal or adenomatous colonic tissue from human subjects were conducted in accordance with the recognized ethical guidelines, for example, Declaration of Helsinki, International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS), Belmont Report, U.S. Common Rule.
Aquamin
Aquamin is a multi-mineral natural product obtained from the skeletal remains of the red marine algae, Lithothamnion sp. (13) and has been used in previous murine studies (14, 15, 24). Aquamin contains calcium and magnesium in an approximately (12:1 ratio), along with measurable levels of 72 other trace minerals. Mineral content was established via an independent laboratory (Advanced Laboratories) using inductively coupled plasma optical emission spectrometry (Supplementary Table S1).
Phase-contrast microscopy and quantification
Colonoids were assessed by phase-contrast microscopy (Hoffman Modulation Contrast - Olympus IX70 with a DP71 digital camera) for changes in size and shape over time. Briefly, photographs of individual colonoids were taken at 2- to 3-day intervals over a 4-week period of growth. Images were scanned and surface area measurements made using Adobe Photoshop CS6 image analysis tool. Changes in surface area between day 8 (1 day after the most recent subculture) and day 13 were generated for numerous individual colonoids per treatment group (i.e., in 10–20 fields with 15–20 individual colonoids per field at 200×). From this, growth indices were calculated. The phase-contrast images were also used to assess the percentage of colonoids expressing the differentiated phenotype, that is, smooth, thick walls, and few tiny surface buds.
Histology and immunohistology
Colonoids were isolated from Matrigel using 2 mmol/L EDTA and fixed in 10% formalin for 1 hour. Fixed colonoids were suspended in HistoGel (Thermo Fisher Scientific) and then processed for histology. Additional details regarding immunohistology processing and antibodies used can be found in Supplementary Table S2 and Supplementary Materials and Methods section.
Confocal fluorescence microscopy
Colonoids were isolated from Matrigel as above. Staining was done using a rabbit polyclonal Ki67 antibody for proliferating cells (ab15580; Abcam) overnight at 4°C. Prolong Gold containing DAPI to identify nuclei (P36935; Life Technologies Molecular Probes) was used as counterstain. Specimens were visualized and imaged with a Leica Inverted SP5X Confocal Microscope System. Additional methodologic details are provided in the Supplementary Methods.
Morphometric analysis
The histologic sections were digitized using the Aperio AT2 whole slide scanner (Leica Biosystems) at 40×. Scanned Images were archived in Aperio eSlide Manager (Version 12.3.2.5030). These images were viewed and analyzed using Aperio ImageScope (Version 12.3.3.5048). Complete details can be found in the Supplementary Methods.
Scanning electron microscopy and transmission electron microscopy
Adenoma colonoid specimens were fixed in situ and processed for scanning electron microscopy (SEM) or transmission electron microscopy (TEM) as described previously (25). More details are provided in the Supplementary Methods.
Proteomic analyses
Adenoma colonoids were isolated from Matrigel using 2 mmol/L EDTA for 15 minutes and then exposed to 8 mol/L urea in 0.1 mol/L TEAB buffer for protein isolation. Proteomic experiments and analysis were carried out in the Proteomics Resource Facility in the Department of Pathology at the University of Michigan, employing mass spectrometry–based Tandem Mass Tag (TMT, Thermo Fisher Scientific; refs. 26, 27). Protein names were retrieved using Uniprot.org, and reactome V63 (reactome.org) was used for pathway enrichment analyses (28) based on the abundance ratio as compared with the individual control (calcium 0.15 mmol/L) for each adenoma with ≤2% FDR. Additional methodologic details are provided in the Supplementary Material.
Statistical analysis
Means and SDs were obtained for discrete morphologic and IHC features as well as for individual proteins. Groups were analyzed by ANOVA followed by Student t test (two-tailed) for unpaired data. Pathways enrichment data reflect Reactome-generated P values based on the number of entities identified in a given pathway as compared with total proteins responsible for that pathway. Data were considered significant at P < 0.05.
Results
Adenoma differentiation in colonoid culture: morphologic and ultrastructural features
Adenoma colonoids from three different individuals were maintained for 30 days under control conditions (0.15 mmol/L calcium) or in medium supplemented with 1.5 mmol/L calcium or with Aquamin to provide either 0.15 or 1.5 mmol/L calcium. Throughout the in-life portion of the study, multiple individual colonoids were examined by phase-contrast microscopy at 2- to 3-day intervals for changes in size and shape. Individual colonoids increased in size over time. Although the rate at which colonoids grew varied with the adenoma (growth indices under control conditions: #584 = 3.9 ± 1.4; #590 = 3.5 ± 2.8; #282 = 2.1 ± 1.0), there was no effect with 1.5 mmol/L calcium or with Aquamin providing calcium up to 1.5 mmol/L (Supplementary Fig. S1).
Although there was no measurable effect on colonoid size, alterations in adenoma morphology could be seen with intervention. Specifically, individual colonoids maintained under low calcium (0.15 mmol/L) conditions (Fig. 1A, a) consisted of a central “core” structure with multiple tiny buds growing out from the surface. When Aquamin providing 0.15 mmol/L calcium was compared with calcium alone at the same concentration, most of the structures were indistinguishable from those maintained under low calcium conditions alone. However, some of the adenoma colonoids demonstrated a loss of tiny buds on the surface and replacement with fewer, larger buds (Fig. 1A, b).
When adenoma colonoids were maintained in 1.5 mmol/L calcium, either alone (Fig. 1A, c) or in Aquamin containing 1.5 mmol/L calcium (Fig. 1A, d), the majority of individual colonoids had a central core structure with few, large surface buds projecting from the core structure. These morphologic differences, which were evident in the phase-contrast images, were confirmed by SEM (Fig. 1A, e and f).
Histologic features of adenoma colonoids from the same treatment groups harvested at day-30 are presented in Fig. 1B. In 0.15 mmol/L calcium (Fig. 1B, g), the surface buds seen in phase-contrast and SEM images were found to be tiny spherical crypts (8–20 cells in cross-section) surrounding a small central lumen. In some places, there was no lumen at all. Cells were cuboidal in shape. Consistent with phase-contrast findings, colonoids maintained in culture medium containing 0.15 mmol/L Aquamin (Fig. 1B, h) demonstrated a mix of morphologies. Tiny crypts similar in morphology to those maintained in 0.15 mmol/L calcium alone could be seen along with large crypts with larger central lumens. When calcium was increased to 1.5 mmol/L (either alone; Fig. 1B, i) or in Aquamin (Fig. 1B, j), most of the tiny crypts were replaced by much larger crypts. The larger crypts (all conditions) consisted of columnar epithelial cells surrounding a large irregularly shaped central lumen. Some small crypts were also seen, but these were fewer (as a percentage of the total). Ultrastructural features of adenoma colonoids growing under control conditions (0.15 mmol/L calcium) or in medium containing 1.5 mmol/L calcium are also shown. Consistent with histologic findings, the electron micrographs demonstrated that under low calcium (0.15 mmol/L) conditions (Fig. 1B, k and l), the cells were cuboidal in shape and surrounded a small lumen. Tight junctures and desmosomes were lacking. Upon treatment with 1.5 mmol/L calcium (Fig. 1B, m and n), colonoids had a very different appearance. The cells were columnar in shape and surrounded a much larger central lumen. Desmosomes (black arrows) and tight junctures (white arrow) could be seen. Both types of junctional complexes were widespread in the colonoids exposed to 1.5 mmol/L calcium.
Phase-contrast and histologic differences were quantified. The bar graph shown in the left of Fig. 1C demonstrates the percentage of colonoids in each condition that demonstrated loss of tiny buds and replacement by a smooth surface. With 1.5 mmol/L calcium (either alone or as part of Aquamin), the majority of individual colonoids expressed this morphologic alteration. A lower percentage of colonoids demonstrated this change in 0.15 mmol/L Aquamin (13% ± 7%), but this was still statistically significant relative to control (2% ± 7%). Quantification of histologic features (number of buds/core structure) is presented in the right of Fig. 1C.
Reversibility of differentiated features in adenoma colonoids
After 30 days of incubation in medium containing 1.5 mmol/L calcium alone or in Aquamin providing 1.5 mmol/L calcium, adenoma colonoids from all three subjects were washed and then incubated under control conditions (i.e., in medium containing 0.15 mmol/L calcium alone; Supplementary Fig. S2). With all three specimens, the morphologic features seen under high calcium conditions (Supplementary Fig. S2a) demonstrated a rapid reversion (i.e., within 6 days) to the low calcium morphology (Supplementary Fig. S2b). With Aquamin (Supplementary Fig. S2c and S2d), similar reversion occurred.
Immunochemical markers of proliferation and differentiation: effects of calcium alone versus Aquamin
Calcium (alone or as part of Aquamin) was evaluated for effects on markers of proliferation and differentiation. Ki67-expressing (proliferating) cells were seen by immunohistology throughout the growing structures in all conditions (Fig. 2A, a–d). Morphometric analysis (Fig. 2B) showed that in the tiny spherical crypts of colonoids maintained in the low calcium environment, 85% ± 9% of the cells were Ki67 positive. In the larger structures, there was a mix of Ki67-positive and Ki67-negative cells (50% ± 15% positive in 1.5 mmol/L calcium and 41% ± 21% positive in Aquamin 1.5 mmol/L). With adenoma colonoids maintained in Aquamin providing 0.15 mmol/L calcium, the percentage of Ki67-positive cells was 64% ± 21%. Confocal fluorescence microscopy was used to obtain a broader perspective on distribution of the proliferation marker. This approach confirmed that Ki67 staining was largely confined to the tiny crypts. Furthermore, it could be seen that where the small crypts were attached to the core structure, virtually all of the staining was in at the outer-facing surface of the colonoid structure (Fig. 2C, e and f).
Figure 3 demonstrates effects of intervention on expression patterns for differentiation markers (CK20, E-cadherin, and occludin). With CK20, most of the cells in the small crypts in low calcium (0.15 mmol/L) culture medium (Fig. 3A, a) were completely negative or demonstrated weak intracellular staining. However, a few cells in this treatment group were strongly positive. In the other three conditions, including Aquamin (0.15 mmol/L; Fig. 3A, b–d), numerous strongly positive cells were seen throughout the crypt.
With E-cadherin, staining was mostly intracellular and diffuse under control conditions (Fig. 3A, e). With all three interventions (Fig. 3A, f–h), strong surface staining was observed in the large crypts. An increase in intracellular staining was also seen with 1.5 mmol/L calcium (alone or in Aquamin; Fig. 3A, g and h), but we did not see an increase in intracellular staining in the low Aquamin treatment group (Fig. 3A, f).
With occludin, cells from colonoid crypts in low calcium medium demonstrated a diffuse intracellular staining pattern (Fig. 3A, i). Colonoids maintained in Aquamin at 0.15 mmol/L (Fig. 3A, j) demonstrated a mixed staining pattern, that is, many of the cells in the tiny spherical crypts demonstrated only diffuse intracellular staining, whereas the larger crypts demonstrated strong staining at cell–cell boundaries and at the apical surface as well as intracellular staining. Under high calcium conditions (with either calcium alone or with Aquamin; Fig. 3A, k and l), intense surface staining was observed in addition to strong intracellular staining. Strong surface staining was observed in both outer-facing cells and those cells sequestered in the interior of the colonoid structure.
Finally, colonoids were stained with an antibody to cleaved caspase-3 as a marker of apoptosis. Although there was little overall staining under any of the conditions (Fig. 3A, m–p), reactivity was greater in colonoids exposed to calcium alone or Aquamin (1.5 mmol/L; Fig. 3A, o and p). Individual cells within the wall of the large crypts and sloughed cells in the crypt lumen were positive. Higher magnification images of these immunomarkers are shown in Supplementary Fig. S3A.
Quantification of immunostained markers using positive pixel count v9 is shown in Fig. 3B. Of note, Aquamin at 0.15 mmol/L demonstrated enhanced staining with CK20 and occludin as compared with control. The markup images generated during this analysis are shown in Supplementary Fig. S3B.
On the basis of the morphologic appearance under phase-contrast microscopy and in histology (and later by confirmation with the IHC expression pattern of the crypts), adenoma colonoids with a thick-walled and smooth surface appearance along with a lack of small buds were consistent with a differentiated phenotype (Figs. 1–3).
Proteomic changes in adenoma colonoids: comparison of calcium alone versus Aquamin
Lysates were prepared from each of the three adenoma colonoids following growth for 30 days. Lysates from each tumor were evaluated (separately) for protein expression changes in response to intervention in comparison with control. Then, the three sets of data were combined. The Venn plots shown in Fig. 4A indicate the total number of proteins demonstrating an average change in expression (increased or decreased) of at least 1.8-fold across the three adenomas with each intervention relative to control, and the overlap between pairs of interventions. The associated scatterplots show the correlation in overlap between the interventions. A total of 223 proteins met this criterion with Aquamin (1.5 mmol/L) compared with 106 with calcium alone. Of these, 83 were common, with a high concordance (r = 0.96; P < 2.2 × 10−16; Fig. 4A, top). With Aquamin (0.15 mmol/L), a total of 43 proteins met the criteria, and of these, 31 overlapped with calcium 1.5 mmol/L (concordance, r = 0.91; P < 1.7 × 10−12; Fig. 4A, middle). When the two Aquamin levels were compared (Fig. 4A, bottom), there was a virtual 100% overlap (r = 0.97; P < 2.2 × 10−16).
Figure 4B demonstrates the distribution of altered proteins (1.8 fold change up and down by individual tumor), showing interindividual variability in response to these interventions. Only a single protein, NF2 (merlin), was found to be upregulated (at least 1.8-fold) in all three tumors with Aquamin 1.5 mmol/L. Three proteins, two metallothionein isoforms and phospholipid-transporting ATPase 1A, were downregulated by Aquamin in all three tumors. With 1.5 mmol/L calcium alone, only two proteins (microsomal glutathione S-transferase 2 and protocadherin fat 1) were downregulated to the same level in all three tumors. With Aquamin (0.15 mmol/L), there were none.
Figure 4C highlights changes occurring in NF2 (merlin). The upper bar graph shows the fold changes with 1.5 mmol/L calcium alone or with Aquamin at either calcium concentration in proteomic assessment. All were statistically higher than control. Of interest, both Aquamin concentrations were also higher than 1.5 mmol/L calcium (2.4- and 1.9-fold vs. 1.5-fold), although the differences were not statistically significant. The bottom panel presents immunostaining results. Both concentrations of Aquamin strongly increased NF2 (merlin) expression, while little effect was observed with calcium alone at either concentration. The upregulation seen with either Aquamin concentration was significantly higher than seen with calcium at 1.5 mmol/L (as well as calcium at 0.15 mmol/L).
Figure 4D shows changes in metallothionein-1E and -1H. With both isoforms, all three interventions led to a statistically significant reduction as compared with control expression.
Table 1A provides a list of upregulated proteins, that is, proteins that were upregulated by an average of 1.8-fold or greater (with ≤2% FDR) across the three adenomas in response to any of the three interventions and statistically different from control with at least one intervention. For comparison, corresponding averages from the other interventions (even if corresponding average values were below 1.8-fold change) are shown. Among proteins of interest in addition to NF2 (merlin) were several keratins, several isoforms of histone H1, that is, proteins involved in terminal differentiation, and olfactomedin-4. Supplementary Table S3 provides a comprehensive list of proteins that were upregulated by an average of 1.8-fold or greater (with ≤2% FDR) across the three adenomas. In some cases, the most highly upregulated proteins did not reach statistical significance because of high SDs. This attests to the variability among individual tumors. The top 18 pathways associated with (statistically significant) upregulated proteins are shown in Table 1B. Not surprisingly, upregulated pathways include those involved in differentiation, growth regulation, cell death, and cellular response to stress.
Relative abundance (average 1.8 fold change or above relative to 0.15 mmol/L calcium of 3 adenomas) . | |||
---|---|---|---|
. | Average FC (from 3 adenomas) . | ||
. | Calcium . | Aquamin . | Aquamin . |
Proteins . | (1.5 mmol/L) . | (0.15 mmol/L) . | (1.5 mmol/L) . |
Proteins common with all 3 Interventions; CA 1.5, AQ 0.15, & AQ 1.5 (2 common proteins) | |||
None significant | |||
Proteins common with 2 Interventions; AQ 0.15 & AQ 1.5 mmol/L (1 common protein) | |||
Merlin (NF2) | 1.5 ± 0.1a | 1.9 ± 0.3a | 2.4 ± 0.7a |
Proteins common with 2 Interventions; CA 1.5 & AQ 1.5 mmol/L (9 significant out of 15 common proteins) | |||
Keratin-10 (KRT10) | 2.0 ± 0.4a | 1.2 ± 0.2 | 5.3 ± 6.4 |
Keratin-2 (KRT2) | 1.9 ± 0.4a | 1.0 ± 0.1 | 4.6 ± 5.4 |
Histone H1.5 (HIST1H1B) | 1.9 ± 0.4a | 1.5 ± 0.8 | 2.8 ± 1.6 |
Histone H1.3 (HIST1H1D) | 1.8 ± 0.4a | 1.5 ± 0.8 | 2.7 ± 1.5 |
60S ribosomal protein L7a (RPL7A) | 1.8 ± 0.3a | 1.6 ± 0.9 | 2.3 ± 1.4 |
Histone H1.0 (H1F0) | 1.8 ± 0.4a | 1.3 ± 0.6 | 2.3 ± 0.9 |
Chromatin target of PRMT1 protein (CHTOP) | 1.9 ± 0.2a | 1.5 ± 0.6 | 2.1 ± 0.7 |
Olfactomedin-4 (OLFM4) | 2.1 ± 0.6a | 1.0 ± 0.0 | 2.0 ± 0.6a |
Brain acid soluble protein 1 (BASP1) | 1.8 ± 0.7 | 0.6 ± 0.1 | 1.8 ± 0.4a |
Upregulated proteins; CA 1.5 mmol/L (3 common proteins) | |||
None significant | |||
Upregulated proteins; AQ 0.15 mmol/L (1 significant out of 5 common proteins) | |||
ATP-dependent RNA helicase (DDX52) | 1.6 ± 0.1a | 2.0 ± 0.3a | 1.6 ± 0.2a |
Upregulated proteins; AQ 1.5 mmol/L (6 significant out of 17 common proteins) | |||
Keratin, type II cytoskeletal 5 (KRT5) | 1.5 ± 0.2a | 1.1 ± 0.3 | 5.8 ± 6.6 |
Histone H1.2 (HIST1H1C) | 1.7 ± 0.3a | 1.5 ± 0.8 | 2.8 ± 1.7 |
Histone H1.4 (HIST1H1E) | 1.7 ± 0.4a | 1.1 ± 0.4 | 2.0 ± 0.6a |
Ribonuclease P protein subunit p38 (RPP38) | 1.3 ± 0.1a | 1.7 ± 0.4a | 1.9 ± 0.7 |
60S ribosomal protein L14 (RPL14) | 1.5 ± 0.1a | 1.4 ± 0.6 | 1.8 ± 0.8 |
Fatty acid–binding protein, liver (FABP1) | 1.5 ± 0.2a | 1.1 ± 0.0 | 1.8 ± 0.4a |
Relative abundance (average 1.8 fold change or above relative to 0.15 mmol/L calcium of 3 adenomas) . | |||
---|---|---|---|
. | Average FC (from 3 adenomas) . | ||
. | Calcium . | Aquamin . | Aquamin . |
Proteins . | (1.5 mmol/L) . | (0.15 mmol/L) . | (1.5 mmol/L) . |
Proteins common with all 3 Interventions; CA 1.5, AQ 0.15, & AQ 1.5 (2 common proteins) | |||
None significant | |||
Proteins common with 2 Interventions; AQ 0.15 & AQ 1.5 mmol/L (1 common protein) | |||
Merlin (NF2) | 1.5 ± 0.1a | 1.9 ± 0.3a | 2.4 ± 0.7a |
Proteins common with 2 Interventions; CA 1.5 & AQ 1.5 mmol/L (9 significant out of 15 common proteins) | |||
Keratin-10 (KRT10) | 2.0 ± 0.4a | 1.2 ± 0.2 | 5.3 ± 6.4 |
Keratin-2 (KRT2) | 1.9 ± 0.4a | 1.0 ± 0.1 | 4.6 ± 5.4 |
Histone H1.5 (HIST1H1B) | 1.9 ± 0.4a | 1.5 ± 0.8 | 2.8 ± 1.6 |
Histone H1.3 (HIST1H1D) | 1.8 ± 0.4a | 1.5 ± 0.8 | 2.7 ± 1.5 |
60S ribosomal protein L7a (RPL7A) | 1.8 ± 0.3a | 1.6 ± 0.9 | 2.3 ± 1.4 |
Histone H1.0 (H1F0) | 1.8 ± 0.4a | 1.3 ± 0.6 | 2.3 ± 0.9 |
Chromatin target of PRMT1 protein (CHTOP) | 1.9 ± 0.2a | 1.5 ± 0.6 | 2.1 ± 0.7 |
Olfactomedin-4 (OLFM4) | 2.1 ± 0.6a | 1.0 ± 0.0 | 2.0 ± 0.6a |
Brain acid soluble protein 1 (BASP1) | 1.8 ± 0.7 | 0.6 ± 0.1 | 1.8 ± 0.4a |
Upregulated proteins; CA 1.5 mmol/L (3 common proteins) | |||
None significant | |||
Upregulated proteins; AQ 0.15 mmol/L (1 significant out of 5 common proteins) | |||
ATP-dependent RNA helicase (DDX52) | 1.6 ± 0.1a | 2.0 ± 0.3a | 1.6 ± 0.2a |
Upregulated proteins; AQ 1.5 mmol/L (6 significant out of 17 common proteins) | |||
Keratin, type II cytoskeletal 5 (KRT5) | 1.5 ± 0.2a | 1.1 ± 0.3 | 5.8 ± 6.6 |
Histone H1.2 (HIST1H1C) | 1.7 ± 0.3a | 1.5 ± 0.8 | 2.8 ± 1.7 |
Histone H1.4 (HIST1H1E) | 1.7 ± 0.4a | 1.1 ± 0.4 | 2.0 ± 0.6a |
Ribonuclease P protein subunit p38 (RPP38) | 1.3 ± 0.1a | 1.7 ± 0.4a | 1.9 ± 0.7 |
60S ribosomal protein L14 (RPL14) | 1.5 ± 0.1a | 1.4 ± 0.6 | 1.8 ± 0.8 |
Fatty acid–binding protein, liver (FABP1) | 1.5 ± 0.2a | 1.1 ± 0.0 | 1.8 ± 0.4a |
NOTE: Values represent average fold change compared with control conditions (0.15 mmol/L calcium) ± SDs. Only statistically significant proteins presented in Table 1A.
Supplementary Table S3 provides a comprehensive list of proteins that were upregulated by an average of 1.8-fold or greater across the three adenomas.
aRepresents significance in upregulation as compared with the control at P < 0.05 level.
Significant pathways (Reactome V63) . | Entities P value . |
---|---|
Activation of DNA fragmentation factor | 1.4 × 10−11 |
Apoptosis induced DNA fragmentation | 1.4 × 10−11 |
Formation of senescence-associated heterochromatin foci | 3.9 × 10−11 |
Apoptotic execution phase | 1.4 × 10−8 |
DNA damage/telomere stress induced senescence | 3.0 × 10−8 |
Cellular senescence | 3.9 × 10−6 |
Apoptosis | 4.6 × 10−6 |
Programmed cell death | 5.3 × 10−6 |
Major pathway of rRNA processing in the nucleolus and cytosol | 1.5 × 10−4 |
rRNA processing in the nucleus and cytosol | 1.9 × 10−4 |
rRNA processing | 2.2 × 10−4 |
Cellular responses to stress | 2.8 × 10−4 |
Cellular responses to external stimuli | 6.3 × 10−4 |
Formation of the cornified envelope | 9.6 × 10−4 |
Metabolism of RNA | 2.8 × 10−3 |
Keratinization | 4.2 × 10−3 |
Type I hemidesmosome assembly | 0.02 |
RHO GTPases activate PAKs | 0.03 |
Significant pathways (Reactome V63) . | Entities P value . |
---|---|
Activation of DNA fragmentation factor | 1.4 × 10−11 |
Apoptosis induced DNA fragmentation | 1.4 × 10−11 |
Formation of senescence-associated heterochromatin foci | 3.9 × 10−11 |
Apoptotic execution phase | 1.4 × 10−8 |
DNA damage/telomere stress induced senescence | 3.0 × 10−8 |
Cellular senescence | 3.9 × 10−6 |
Apoptosis | 4.6 × 10−6 |
Programmed cell death | 5.3 × 10−6 |
Major pathway of rRNA processing in the nucleolus and cytosol | 1.5 × 10−4 |
rRNA processing in the nucleus and cytosol | 1.9 × 10−4 |
rRNA processing | 2.2 × 10−4 |
Cellular responses to stress | 2.8 × 10−4 |
Cellular responses to external stimuli | 6.3 × 10−4 |
Formation of the cornified envelope | 9.6 × 10−4 |
Metabolism of RNA | 2.8 × 10−3 |
Keratinization | 4.2 × 10−3 |
Type I hemidesmosome assembly | 0.02 |
RHO GTPases activate PAKs | 0.03 |
In a similar manner, we assessed the most downregulated proteins across the three adenomas with all three interventions (i.e., >1.8-fold with ≤2% FDR). Proteins downregulated by an average of 1.8-fold or greater across the three adenomas in response to any of the three interventions are shown in Supplementary Table S4, along with corresponding averages from the other interventions. Many of the most downregulated proteins are involved in lipid metabolism, energy production, oxidative stress, and metal transport.
Effects of calcium and Aquamin on growth and differentiation of colonoids from histologically normal colon tissue
Colonoid cultures were established from three different histologically normal colon tissue specimens (representing three individuals) and maintained for a 2-week period. Normal colon tissue colonoids differed from adenoma colonoids in several ways. In addition to their more stringent growth medium requirement and failure to survive long term in culture under the conditions used here (see Materials and Methods section), normal tissue-derived colonoids were significantly different in appearance. As observed by phase-contrast microscopy (Fig. 5), cultures of normal tissue colonoids contained a mix of two morphologically distinct presentations, that is, thin-walled, translucent “cystic” structures, and budding structures that resembled those seen in the adenoma cultures. Of interest in regard to the current study, there was little difference between normal tissue–derived colonoids maintained under low calcium conditions (0.25 mmol/L calcium; Fig. 5A) and those treated with 1.5 mmol/L calcium (Fig. 5B) or Aquamin 1.5 mmol/L (Fig. 5C). At the histologic level (Fig. 5), normal tissue–derived colonoids were made up of structures with large circular lumens surrounded by a single layer of flat, cuboidal cells or columnar epithelial cells. As expected based on phase-contrast microscopy, there was little difference in appearance between colonoids grown under low calcium conditions (Fig. 5D) and those exposed to elevated calcium (Fig. 5E) or Aquamin (Fig. 5F). As part of the analysis, normal colon tissue–derived colonoids were stained for Ki67 and CK20. There was a mix of Ki67-positive cells and Ki67-negative cells, with no observable difference in staining as a function of calcium concentration (Fig. 5G–I). Intense CK20 staining was seen throughout the crypts, independent of calcium level (Fig. 5J–L). Finally, we saw no caspase-3 expression under control conditions (Fig. 5M), but a few positive cells were present in the normal colon sections treated with calcium (Fig. 5N) or Aquamin (Fig. 5O).
Discussion
In the studies described here, we compared responses of three different human colon adenomas in colonoid culture to intervention with calcium alone versus calcium as part of a natural product (Aquamin) that consists of magnesium and additional trace elements along with calcium. The colonoid cultures were established from tumors with the diagnosis of “large adenoma.” The study had two overall goals. First was to determine whether (and to what extent) human colon adenoma tissue in colonoid culture could be used to study the process of differentiation in the colonic epithelium. To address this issue, we utilized calcium, the quintessential epithelial differentiation inducer (29), as a way to assess phenotypic changes. It is well known from monolayer cell culture studies that optimal epithelial growth occurs at calcium levels of 0.05 to 0.15 mmol/L and that increasing the extracellular calcium level fosters differentiation (29). This was the first study, however, to directly assess calcium-mediated differentiation in actual human colon tumor specimens in colonoid culture. A second goal was to determine whether the combination of calcium and additional trace elements (i.e., Aquamin) would have beneficial activity beyond that seen with calcium alone. Past studies have demonstrated better suppression of colon polyp formation/progression in a mouse model with Aquamin relative to calcium alone (15), and better growth-regulating activity in human colon carcinoma cell lines in monolayer culture (16, 17), but the use of human colon adenoma tissue in colonoid culture provided an opportunity to directly compare the interventions against actual (growing) human colon polyp tissue.
Both study goals were achieved. Calcium alone at 1.5 mmol/L induced differentiation in all three tumor specimens as indicated by morphologic, histologic, and ultrastructural changes as compared with control. This was accompanied by a growth fraction reduction (reduced Ki67 expression) and by upregulation of differentiation markers. Several additional differentiation-related proteins were also upregulated as indicated by proteomic analysis. Thus, in spite of the inherent variability and heterogeneity of human adenomas (30), we were able to document a measurable response to calcium in all three adenomas. Capacity to induce differentiation in large colon adenomas is of interest because the expression of differentiated features is associated with better prognosis in endoscopically removed large adenomas (31, 32), just as it is in fully malignant colon adenocarcinomas (33, 34). Development of resistance to the prodifferentiating and growth-regulating activity of calcium has been demonstrated with colon epithelial cells in monolayer culture (16), and resistance of large adenomas to growth suppression by vitamin D (calcium-regulating) has been suggested as a mechanism allowing for outgrowth and progression of such tumors in the face of calcium (35). The data presented here indicate that, at least in the case of the three specimens studied to date, the tumors retain a measure of calcium responsiveness even when they have reached the large adenoma stage. Some colon cancer chemoprevention strategies depend on suppression prior to tumor initiation or at the earliest stages of abnormal growth (36). Those strategies would likely have little impact on the tumors that have reached the large stage. In contrast, beneficial effects from calcium might still be seen with polyps that have already reached a detectable size.
In addition to demonstrating adenoma differentiation in response to calcium, we were also able to show additional effects with Aquamin as compared with calcium alone. Of particular interest, prodifferentiation activity was observed when Aquamin was included at a concentration providing only 0.15 mmol/L calcium. Even at this low Aquamin level, some colonoids in each tumor underwent differentiation as detected by morphologic alterations and altered biomarker expression (i.e., reduced Ki67 staining and increased CK20 and occludin expression along with membrane localization of E-cadherin). Perhaps of most interest was NF2 (merlin). This protein was significantly upregulated with both Aquamin concentrations while there was little change in response to calcium (as shown in IHC expression). NF2 (merlin) is downstream of P21, a calcium-regulated tumor growth suppressor (37, 38), and is a component of other signaling pathways that are known to have tumor growth-suppressing activity (39, 40). These data support earlier findings from animal studies (15), suggesting that the presence of additional trace elements along with calcium has effectiveness as a growth regulator in the colon over that seen with calcium alone. This is of interest because the use of calcium supplements at high levels is complicated by unwanted side effects, including increasing the risk of cardiovascular events (11, 12).
How the combination of trace elements and calcium in Aquamin promotes differentiation at the low overall calcium concentration is not fully understood. Several different trace elements represented in the natural product (including members of the lanthanide family) bind to proteins involved in calcium signaling/mobilization (41–45). One of these, the extracellular calcium sensing receptor, plays a critical role in growth-regulating responses to calcium in the colon (46). Producing a “left-shift” in the response to calcium is one possible mechanism (17, 47). At the same time, of course, other elements in the natural product could have growth-regulating activity, as well. It would be unwise at this point to rule out their involvement (either functioning with calcium or independently) as part of the mechanism.
As a control, we assessed calcium alone and Aquamin for effects on features of differentiation in colonoids derived from histologically normal colonic tissue. Neither produced a change in growth characteristics or morphologic features. The lack of effect on normal tissue structure is largely consistent with observations of Bostic and colleagues (48) who demonstrated only minimal effects of calcium intervention on the intact colonic mucosa during a chemoprevention trial. Thus, it seems unlikely that Aquamin will produce manifestations of toxicity when used in a chemoprevention regimen. In addition, by reducing the amount of calcium needed for efficacy, this might reduce toxicities associated with high calcium supplement intake.
Finally, although our use of the proteomic platform was, primarily, to identify protein changes that are linked to calcium-mediated differentiation, the proteomic approach produced a massive amount of additional data, and analyzing the information effectively is far beyond the scope of a single article. For example, there were large alterations in expression of several relevant proteins, but seen in only one or two of the tumors. Among these were cancer suppressors, that is, BRCA1-associated protein and olfactomedin-4 (both up-regulated; refs. 49, 50). Interestingly, in light of the fact that all three tumors had mutations in DNA repair pathway genes, was the finding that several proteins involved in DNA repair (e.g., methylated-DNA - protein methyltransferase, DNA repair protein complementing XP-C and mismatch repair endonuclease PMS2) were increased. Determining what accounts for this heterogeneity will be challenging. Another challenge will be to determine the relationship between biological activity (i.e., ability to undergo differentiation) and downregulated proteins. Numerous proteins were reduced in response to each of the interventions. Yet, beyond noting that many of these proteins are involved in lipid metabolism and energy cycles, no attempt was made to understand their impact. This will require additional work.
In summary, it is well known that calcium has growth-regulating activity in the colon. Our past studies have shown that the combination of calcium and additional trace elements has better colon epithelial cell growth–regulatory activity than that seen with calcium alone. The studies presented here demonstrate that calcium does, in fact, affect growth in human colon adenomas obtained from large tumor specimens in colonoid culture. The studies show, furthermore, that a multi-mineral approach has the capacity to modulate structure and function in these specimens at calcium concentration that are ineffective with calcium alone. At the same time, there is no evidence of toxicity for normal colonic mucosa in colonoid culture. Thus, this work has a high degree of translational potential. Ultimately, however, fostering the use of Aquamin as a colon chemopreventative agent is not the primary goal of this work. Rather, our goal is proof of concept, that is, demonstrating that providing additional trace elements along with calcium has efficacy over that seen with calcium alone.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Authors' Contributions
Conception and design: S.D. McClintock, D. Attili, M.K. Dame, D.K. Turgeon, J. Varani, M.N. Aslam
Development of methodology: S.D. McClintock, D. Attili, M.K. Dame, V. Basrur, D.K. Turgeon, J. Varani, M.N. Aslam
Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): S.D. McClintock, D. Attili, M.K. Dame, A. Richter, A.R. Reddy, V. Basrur, D.K. Turgeon, J. Varani, M.N. Aslam
Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): S.D. McClintock, J.A. Colacino, D. Attili, M.K. Dame, A. Richter, A.R. Reddy, A.H. Rizvi, J. Varani, M.N. Aslam
Writing, review, and/or revision of the manuscript: S.D. McClintock, J.A. Colacino, D. Attili, M.K. Dame, V. Basrur, A.H. Rizvi, D.K. Turgeon, J. Varani, M.N. Aslam
Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): J. Varani, M.N. Aslam
Study supervision: J. Varani, M.N. Aslam
Acknowledgments
This study was supported by NIH grants CA181855, CA201782 (to J. Varani), ES028802 (to J.A. Colacino), CA046592 (University of Michigan Comprehensive Cancer Center core grant), and by support from The Rose and Lawrence C. Page Foundation (D.K. Turgeon), the Ravitz Foundation (J.A. Colacino), MCubed (J.A. Colacino, J. Varani), and Michigan Institute for Clinical & Health Research (UL1TR002240). Part of the proteomics work was supported by The University of Michigan Center for Gastrointestinal Research (5 P30 DK034933)/Department of Pathology pilot grant (M.N. Aslam). We thank Marigot LTD. for providing Aquamin as a gift. We thank the Translational Tissue Modeling Laboratory for providing access to human adenoma colonoid cultures, the Proteomic Core (Alexey Nesvizhskii, Director) for help with proteomic data acquisition (Kevin Conlon) and analysis (Dattatreya Mellacheruvu), the In Vivo Animal Core for preparation of samples for histology, the Histology and Immunohistology laboratory (University of Michigan Comprehensive Cancer Center) for immunostaining (Tina Fields), the Microscopy and Imaging Laboratory for help with confocal fluorescence microscopy, scanning electron microscopy, and TEM, and the Slide-Scanning Services (Peter Ouillette) of the Pathology Department for help with slide scanning and morphometric analysis.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.